Drug shortage
Gadoterate Meglumine Injection · Jiangsu Hengrui Pharmaceuticals Co., Ltd.
FDA drug shortage · To Be Discontinued · updated Jun 30, 2026
Key facts
| Generic name | Gadoterate Meglumine Injection |
|---|---|
| Company | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| Presentation | Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Medical Imaging |
| Package NDCs | 65219-082-10 |
| First posted | Jun 30, 2026 |
| Last updated | Jun 30, 2026 |
| Discontinued | Jun 30, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: